킵스파마

256940KOSDAQ의약품 제조업

42.8 / 100

Reference Date: 2026-04-13

Financial Score10.5 / 40

News Sentiment16.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly up 1.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Kipsis Pharma operates three main business segments: OLED equipment development and supply, battery recycling, and pharmaceutical manufacturing and sales. In the OLED segment, the company is expanding its global market through high-precision equipment and FMM mask development. The recycling segment produces lead ingots from recycled batteries for supply to battery manufacturers. Additionally, the biopharma segment is gaining growth momentum through the development of anticancer drugs and digital therapeutics.

Number of Employees

96people

Average Salary

55.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.804.0Point

PBR

2.04Industry Average 1.041.0Point

2.0x industry avg (risky)

ROE

-14.33Industry Average 4.420.0Point

Well below industry avg

Debt Ratio

77.31Industry Average 11.980.0Point

6.5x industry avg (risky)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲35.9% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.8% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 2Neutral 0Negative 0Average Sentiment Score 80

Positive
킵스파마, 지난해 매출 1701억으로 33%↑…"제약·바이오 체질 개선...
킵스파마는 지난해 연결 기준 매출 1701억원을 기록하며 전년 대비 33% 성장했고, 별도 기준 매출도 6배 이상 증가하며 제약·바이오 사업 전환 효과를 보였다.
Positive
'합병 시너지' 킵스파마, 작년 매출 1701억…전년비 33%↑
킵스파마는 제약·바이오 사업 부문 합병 시너지로 지난해 연결 매출이 33% 성장했으며, 별도 실적도 흑자 전환하는 등 성공적인 체질 개선을 증명했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 8,300Won52-week high 20,95052-week low 6,600

1-month return3.0Point

1m 1.59% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral본점소재지변경2026-03-31
Neutral정기주주총회결과2026-03-31
Neutral사업보고서 (2025.12)2026-03-23
Neutral감사보고서제출2026-03-20
Neutral[기재정정]주주총회집중일개최사유신고2026-03-16